Flt3-mutated Acute Myeloid Leukemia

• CLINICAL_TRIALS research · 2026-03-04
  Clinical Trial Update: A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia [Phase 1, Phase 2]

  Clinical trial update for a first-line combination of gilteritinib, venetoclax, and azacitidine in newly diagnosed acute myeloid leukemia, i…